Cipla gets seven USFDA observations for Pithampur plant after follow-up inspection

The US drug regulator issued seven observations after an eight-day inspection of Cipla’s Pithampur facility. The company said it will respond within the stipulated timeline.

Leave a Reply

Your email address will not be published. Required fields are marked *